Biot-EADPTGHSY-OH

Ref. 3D-PP45845

Informação sobre produto

• Nome: Biot-EADPTGHSY-OH
• Sinónimos: Biot-Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr-OH

Descrição

Peptide Biot-EADPTGHSY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Biot-EADPTGHSY-OH include the following: TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: evidence for further processing in the endoplasmic reticulum Y Wang , DS Guttoh, MJ Androlewicz - Melanoma Research, 1998 - journals.lww.comhttps://journals.lww.com/melanomaresearch/abstract/1998/08000/TAP_prefers_to_transport_melanoma_antigenic.8.aspx Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2 W Ma, C Germeau, N Vigneron - journal of cancer, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20038 Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B* 44: 02 can be improved by acid treatment or fixation of target cells V Stroobant, N Demotte, RM Luiten - European journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201141954 Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 S Yamasaki, T Okino, NG Chakraborty - Cancer Immunology , 1995 - Springerhttps://link.springer.com/article/10.1007/BF01519901 A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules RM Luiten, N Demotte, J Tine - Tissue Antigens: Brief , 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-0039.2000.560110.x Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-κB Q Su, H Song, P Huang, C Zhang , J Yang , D Kong - Bioactive materials, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2452199X21001523 Tumor-specific shared antigenic peptides recognized by human T cells P Van Der Bruggen , Y Zhang , P Chaux - Immunological , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-065X.2002.18806.x Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide ML Salgaller, JS Weber, S Koenig, JR Yannelli - Cancer Immunology , 1994 - Springerhttps://link.springer.com/article/10.1007/BF01525316 Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8 (+) T-cells' release of granulocyte-macrophage colony-stimulating MJ Maeurer , D Martin, E Elder , WJ Storkus - Clinical cancer research , 1996 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/2/1/87/33599 Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. M DiBrino, KC Parker, J Shiloach - (Baltimore, Md.: 1950 , 1994 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/152/2/620/27215 A structurally modified, peptidase-resistant analog of human tumor antigen MZ2-E is a potent activator of anti-melanoma cytotoxic T lymphocytes M Ayyoub, B Monsarrat, H Mazarguil - Immunology , 1997 - infona.plhttps://www.infona.pl/resource/bwmeta1.element.elsevier-1c7b256d-f5a9-3745-9527-e9ad2671145d Activation of anti-tumor cytotoxic T lymphocytes by non-natural ligands: structural and pharmacological studies M Ayyoub, B Monsarrat, H Mazarguil - Fundamental and Clinical , 1998 - infona.plhttps://www.infona.pl/resource/bwmeta1.element.elsevier-a4a51dce-6386-3593-bb06-8c5fb058fbc1 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Katja Nilges, Hanni Höhn, Henryk Pilch, Claudia Neukirch K Freitag, PJ Talbot , MJ Maeurer - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=42484c04bb79d75c8ec3ae0ecfa79514359c66da HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44 (∗) IF Luescher, P Romero, D Kuznetsov, D Rimoldi - Journal of Biological , 1996 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)95440-2/abstract Synthesis of a radioiodinated photoreactive MAGE-1 peptide derivative and photoaffinity labeling of cell-associated human leukocyte antigen-A1 molecules F Anjuere, A Layer, JC Cerottini, C Servis - Analytical , 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269785713796 Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. E Celis, V Tsai, C Crimi, R DeMars - Proceedings of the , 1994 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.91.6.2105 Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development DJ Kittlesen, LW Thompson, PH Gulden - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/5/2099/42863 Monoclonal and recombinant antibodies with T cell receptor-like reactivity A Ziegler, PG Coulie , B Uchaà „ska-Ziegler - Targeted Therapies in Cancer, 2007 - Springerhttps://link.springer.com/content/pdf/10.1007/978-3-540-46091-6.pdf#page=231

• Marca: Biosynth